Exim CVE-2019-15846 and Sophos Products
This article provides information on Exim vulnerability CVE-2019-15846 and how it impacts Sophos products
Applies to the following Sophos product(s) and version(s)
PureMessage for Unix
Sophos Central Email
Sophos Email Appliance
Cyberoam
Sophos UTM Software Appliance
PureMessage for Microsoft Exchange
Reflexion
Overview
CVE-2019-15846 outlines a vulnerability in Exim whereby a specially crafted SNI ending can be utilized to run arbitrary code on the vulnerable server
This vulnerability is not exploitable on any Sophos products, see the table below for more information.
Sophos Email Products and CVE-2019-15846
| Product | Vulnerable | Further information |
|---|---|---|
| Sophos XG Firewall | No | The TLS headers that are used to exploit this vulnerability are stripped by the product before reaching the vulnerable Exim code. * |
| Sophos UTM | No | The TLS headers that are used to exploit this vulnerability are stripped by the product before reaching the vulnerable Exim code. * |
| Sophos Email on Central | No | Product doesn’t utilize Exim |
| Sophos Email Appliance | No | Product doesn’t utilize Exim |
| Puremessage for Unix | No | Product doesn’t utilize Exim |
| Puremessage for Exchange | No | Product doesn’t utilize Exim |
| Cyberoam | No | Product doesn’t utilize Exim |
| Reflexion | No | Product doesn’t utilize Exim |
* Despite this vulnerability not being exploitable due to the current architecture of the Sophos XG and Sophos UTM products, we do still plan on releasing a patch for Exim on these platforms in an upcoming Maintenance Release.
Related information
Sign up to the Sophos Support SMS Notification Service to get the latest product release information and critical issues.
Feedback and contact
If you’ve spotted an error or would like to provide feedback on this article, please use the section below to rate and comment on the article.
This is invaluable to us to ensure that we continually strive to give our customers the best information possible.Article appears in the following topics
